Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Domaoal

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Antiviral Research|January 6, 2015
Pre-steady state kinetic analysis of HIV-1 reverse transcriptase for non-canonical ribonucleoside triphosphate incorporation and DNA synthesis from ribonucleoside-containing DNA templateLaura A Nguyen, Robert A Domaoal, Edward M Kennedy, et al.
Journal of Chemical Information and Modeling|April 21, 2009
Discovery of wild-type and Y181C mutant non-nucleoside HIV-1 reverse transcriptase inhibitors using virtual screening with multiple protein structuresSara E Nichols, Robert A Domaoal, Vinay V Thakur, et al.
Journal of the American Chemical Society|August 23, 2011
Efficient discovery of potent anti-HIV agents targeting the Tyr181Cys variant of HIV reverse transcriptaseWilliam L Jorgensen, Mariela Bollini, Vinay V Thakur, et al.
Journal of Medicinal Chemistry|November 16, 2011
Computationally-guided optimization of a docking hit to yield catechol diethers as potent anti-HIV agentsMariela Bollini, Robert A Domaoal, Vinay V Thakur, et al.
Journal of Molecular Biology|June 12, 2010
K65R and K65A substitutions in HIV-1 reverse transcriptase enhance polymerase fidelity by decreasing both dNTP misinsertion and mispaired primer extension efficienciesScott J Garforth, Robert A Domaoal, Chisanga Lwatula, et al.
Journal of Medicinal Chemistry|October 9, 2007
From docking false-positive to active anti-HIV agentGabriela Barreiro, Joseph T Kim, Cristiano R W Guimarães, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Optimization of pyrimidinyl- and triazinyl-amines as non-nucleoside inhibitors of HIV-1 reverse transcriptaseVinay V Thakur, Joseph T Kim, Andrew D Hamilton, et al.
Journal of the American Chemical Society|November 30, 2006
FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptaseJoseph T Kim, Andrew D Hamilton, Christopher M Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2010
Eastern extension of azoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase; cyano group alternativesCheryl S Leung, Jacob G Zeevaart, Robert A Domaoal, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2016
Discovery, characterization, and lead optimization of 7-azaindole non-nucleoside HIV-1 reverse transcriptase inhibitorsRichard A Stanton, Xiao Lu, Mervi Detorio, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Antiviral Research|January 6, 2015
Pre-steady state kinetic analysis of HIV-1 reverse transcriptase for non-canonical ribonucleoside triphosphate incorporation and DNA synthesis from ribonucleoside-containing DNA templateLaura A Nguyen, Robert A Domaoal, Edward M Kennedy, et al.
Journal of Chemical Information and Modeling|April 21, 2009
Discovery of wild-type and Y181C mutant non-nucleoside HIV-1 reverse transcriptase inhibitors using virtual screening with multiple protein structuresSara E Nichols, Robert A Domaoal, Vinay V Thakur, et al.
Journal of the American Chemical Society|August 23, 2011
Efficient discovery of potent anti-HIV agents targeting the Tyr181Cys variant of HIV reverse transcriptaseWilliam L Jorgensen, Mariela Bollini, Vinay V Thakur, et al.
Journal of Medicinal Chemistry|November 16, 2011
Computationally-guided optimization of a docking hit to yield catechol diethers as potent anti-HIV agentsMariela Bollini, Robert A Domaoal, Vinay V Thakur, et al.
Journal of Molecular Biology|June 12, 2010
K65R and K65A substitutions in HIV-1 reverse transcriptase enhance polymerase fidelity by decreasing both dNTP misinsertion and mispaired primer extension efficienciesScott J Garforth, Robert A Domaoal, Chisanga Lwatula, et al.
Journal of Medicinal Chemistry|October 9, 2007
From docking false-positive to active anti-HIV agentGabriela Barreiro, Joseph T Kim, Cristiano R W Guimarães, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Optimization of pyrimidinyl- and triazinyl-amines as non-nucleoside inhibitors of HIV-1 reverse transcriptaseVinay V Thakur, Joseph T Kim, Andrew D Hamilton, et al.
Journal of the American Chemical Society|November 30, 2006
FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptaseJoseph T Kim, Andrew D Hamilton, Christopher M Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2010
Eastern extension of azoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase; cyano group alternativesCheryl S Leung, Jacob G Zeevaart, Robert A Domaoal, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2016
Discovery, characterization, and lead optimization of 7-azaindole non-nucleoside HIV-1 reverse transcriptase inhibitorsRichard A Stanton, Xiao Lu, Mervi Detorio, et al.
Pageof 4